SEMCO TECHNOLOGIES SAS (ALSEM.PA) Fundamental Analysis & Valuation

EPA:ALSEM • FR0014010H01

Current stock price

32.47 EUR
+0.92 (+2.92%)
Last:

This ALSEM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALSEM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALSEM was profitable.
ALSEM.PA Yearly Net Income VS EBIT VS OCF VS FCFALSEM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 5M 10M

1.2 Ratios

  • The Return On Assets of ALSEM (18.88%) is better than 85.07% of its industry peers.
  • The Return On Equity of ALSEM (45.60%) is better than 88.06% of its industry peers.
  • ALSEM's Return On Invested Capital of 39.86% is amongst the best of the industry. ALSEM outperforms 95.52% of its industry peers.
Industry RankSector Rank
ROA 18.88%
ROE 45.6%
ROIC 39.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSEM.PA Yearly ROA, ROE, ROICALSEM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 10 20 30 40 50

1.3 Margins

  • With a decent Profit Margin value of 20.82%, ALSEM is doing good in the industry, outperforming 62.69% of the companies in the same industry.
  • The Operating Margin of ALSEM (29.31%) is better than 70.15% of its industry peers.
  • With a decent Gross Margin value of 53.65%, ALSEM is doing good in the industry, outperforming 67.16% of the companies in the same industry.
Industry RankSector Rank
OM 29.31%
PM (TTM) 20.82%
GM 53.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSEM.PA Yearly Profit, Operating, Gross MarginsALSEM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALSEM.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALSEM is creating value.
  • The number of shares outstanding for ALSEM remains at a similar level compared to 1 year ago.
  • ALSEM has a worse debt/assets ratio than last year.
ALSEM.PA Yearly Shares OutstandingALSEM.PA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M 8M 10M
ALSEM.PA Yearly Total Debt VS Total AssetsALSEM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 12.16 indicates that ALSEM is not in any danger for bankruptcy at the moment.
  • ALSEM has a Altman-Z score of 12.16. This is in the better half of the industry: ALSEM outperforms 71.64% of its industry peers.
  • ALSEM has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • ALSEM has a Debt to Equity ratio (0.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 12.16
ROIC/WACC3.37
WACC11.82%
ALSEM.PA Yearly LT Debt VS Equity VS FCFALSEM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 5M 10M 15M

2.3 Liquidity

  • ALSEM has a Current Ratio of 1.75. This is a normal value and indicates that ALSEM is financially healthy and should not expect problems in meeting its short term obligations.
  • ALSEM has a worse Current ratio (1.75) than 85.07% of its industry peers.
  • ALSEM has a Quick Ratio of 1.31. This is a normal value and indicates that ALSEM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALSEM (1.31) is worse than 82.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.31
ALSEM.PA Yearly Current Assets VS Current LiabilitesALSEM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALSEM.PA Growth Analysis

3.1 Past

  • The earnings per share for ALSEM have decreased strongly by -15.81% in the last year.
  • Looking at the last year, ALSEM shows a decrease in Revenue. The Revenue has decreased by -5.36% in the last year.
EPS 1Y (TTM)-15.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ALSEM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.11% yearly.
  • Based on estimates for the next years, ALSEM will show a quite strong growth in Revenue. The Revenue will grow by 19.47% on average per year.
EPS Next Y42.42%
EPS Next 2Y36.55%
EPS Next 3Y35.37%
EPS Next 5Y31.11%
Revenue Next Year8.86%
Revenue Next 2Y15.94%
Revenue Next 3Y18.85%
Revenue Next 5Y19.47%

3.3 Evolution

ALSEM.PA Yearly Revenue VS EstimatesALSEM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 20M 40M 60M
ALSEM.PA Yearly EPS VS EstimatesALSEM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALSEM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALSEM is valuated quite expensively with a Price/Earnings ratio of 49.95.
  • Based on the Price/Earnings ratio, ALSEM is valued a bit more expensive than the industry average as 70.15% of the companies are valued more cheaply.
  • ALSEM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.79.
  • With a Price/Forward Earnings ratio of 26.83, ALSEM can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALSEM is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of ALSEM to the average of the S&P500 Index (23.80), we can say ALSEM is valued inline with the index average.
Industry RankSector Rank
PE 49.95
Fwd PE 26.83
ALSEM.PA Price Earnings VS Forward Price EarningsALSEM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALSEM is valued a bit more expensive than the industry average as 67.16% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.82
ALSEM.PA Per share dataALSEM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • ALSEM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ALSEM's earnings are expected to grow with 35.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.18
PEG (5Y)N/A
EPS Next 2Y36.55%
EPS Next 3Y35.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALSEM.PA Dividend Analysis

5.1 Amount

  • ALSEM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALSEM.PA Fundamentals: All Metrics, Ratios and Statistics

SEMCO TECHNOLOGIES SAS

EPA:ALSEM (3/18/2026, 7:00:00 PM)

32.47

+0.92 (+2.92%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners14.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap333.47M
Revenue(TTM)32.00M
Net Income(TTM)6.66M
Analysts85
Price Target35.09 (8.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)21.99%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.71%
EPS NY rev (3m)-6.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.86%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 49.95
Fwd PE 26.83
P/S 10.42
P/FCF N/A
P/OCF N/A
P/B 22.82
P/tB 23.59
EV/EBITDA 33.82
EPS(TTM)0.65
EY2%
EPS(NY)1.21
Fwd EY3.73%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.12
BVpS1.42
TBVpS1.38
PEG (NY)1.18
PEG (5Y)N/A
Graham Number4.56
Profitability
Industry RankSector Rank
ROA 18.88%
ROE 45.6%
ROCE 53.43%
ROIC 39.86%
ROICexc 39.92%
ROICexgc 41.03%
OM 29.31%
PM (TTM) 20.82%
GM 53.65%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.28
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.31
Altman-Z 12.16
F-ScoreN/A
WACC11.82%
ROIC/WACC3.37
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y42.42%
EPS Next 2Y36.55%
EPS Next 3Y35.37%
EPS Next 5Y31.11%
Revenue 1Y (TTM)-5.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year8.86%
Revenue Next 2Y15.94%
Revenue Next 3Y18.85%
Revenue Next 5Y19.47%
EBIT growth 1Y-12.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.12%
EBIT Next 3Y35.59%
EBIT Next 5Y32.56%
FCF growth 1Y149.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.29%
OCF growth 3YN/A
OCF growth 5YN/A

SEMCO TECHNOLOGIES SAS / ALSEM.PA Fundamental Analysis FAQ

What is the fundamental rating for ALSEM stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSEM.PA.


What is the valuation status for ALSEM stock?

ChartMill assigns a valuation rating of 2 / 10 to SEMCO TECHNOLOGIES SAS (ALSEM.PA). This can be considered as Overvalued.


How profitable is SEMCO TECHNOLOGIES SAS (ALSEM.PA) stock?

SEMCO TECHNOLOGIES SAS (ALSEM.PA) has a profitability rating of 4 / 10.


What is the expected EPS growth for SEMCO TECHNOLOGIES SAS (ALSEM.PA) stock?

The Earnings per Share (EPS) of SEMCO TECHNOLOGIES SAS (ALSEM.PA) is expected to grow by 42.42% in the next year.